부산대학교 도서관

Journal of Clinical Pharmacology. December 2007, Vol. 47 Issue 12, p1588, 1 p.

Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Rubinstein L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Zlott J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Coyne GO; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Chung V; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.; Newman EM; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.; Lenz HJ; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.; Kelly K; University of California Davis Cancer Center, Sacramento, CA, USA.; International Association for the Study of Lung Cancer, Denver, CO, USA.; Villaruz LC; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.; Konaté MM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Ferry-Galow KV; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Wang L; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Kinders RJ; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Parchment RE; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Covey JM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Holleran JL; Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA.; Piekarz RL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Miller SB; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Juwara L; Clinical Monitoring Research Program, Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Beumer JH; Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA.; Johns Hopkins University, Baltimore, MD, USA.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA. doroshoj@mail.nih.gov.; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. doroshoj@mail.nih.gov.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Waldeck-Weiermair M; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, A-8010 Graz, Austria.; Das AA; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Covington TA; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Meitzler JL; Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892.; Doroshow JH; Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892.; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD 20892.; Duan J; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Fong YW; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Kaynert J; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Yadav S; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Dutta T; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Spyropoulos F; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.; Pandey AK; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.; Michel T; Heart and Vascular Institute, Mass General Brigham, Boston, MA 02115.

Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Ahmed J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Center for Cancer Research, National Cancer Instiute, Bethesda, Maryland, USA.; O'Sullivan Coyne G; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Center for Cancer Research, National Cancer Instiute, Bethesda, Maryland, USA.; Rubinstein LV; Biometric Research Program, National Cancer Institute Division of Cancer Treatment and Diagnosis, Bethesda, Maryland, USA.; Shin SJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Center for Cancer Research, National Cancer Instiute, Bethesda, Maryland, USA.; Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Center for Cancer Research, National Cancer Instiute, Bethesda, Maryland, USA.; Bruns A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Augustine B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Mukherjee J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Ma N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Fino K; Clinical Pharmacodynamic Biomarkers Program, National Cancer Institute Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Fung KL; Clinical Pharmacodynamic Biomarkers Program, National Cancer Institute Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Ferry-Galow KV; Clinical Pharmacodynamic Biomarkers Program, National Cancer Institute Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Johnson BC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Parchment RE; Clinical Pharmacodynamic Biomarkers Program, National Cancer Institute Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Streicher H; National Cancer Institute Cancer Therapy Evaluation Program, Bethesda, Maryland, USA.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Center for Cancer Research, National Cancer Instiute, Bethesda, Maryland, USA.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA chenali@mail.nih.gov.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Dexheimer TS; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, 21702. Electronic address: thomas.dexheimer@nih.gov.; Coussens NP; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, 21702.; Silvers T; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, 21702.; Juneja P; Molecular Characterization and Clinical Assay Development Laboratory, Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, 21702.; Jones E; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, 21702.; Gore SD; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892.; Kunkel MW; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892.; Teicher BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892.

Publisher: SAGE Publications Country of Publication: United States NLM ID: 101697563 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2472-5560 (Electronic) Linking ISSN: 24725552 NLM ISO Abbreviation: SLAS Discov Subsets: MEDLINE

Kalen JD; Small Animal Imaging Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Tatum JL; Office of the Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute NIH, Bethesda, MD, USA.; Jacobs PM; Office of the Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute NIH, Bethesda, MD, USA. jacobsp@mail.nih.gov.; Doroshow JH; Office of the Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute NIH, Bethesda, MD, USA.

Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: In Process; MEDLINE

Jagu S; National Cancer Institute, Bethesda, Maryland, USA.; Smith MA; National Cancer Institute, Bethesda, Maryland, USA.; Seibel NL; National Cancer Institute, Bethesda, Maryland, USA.; Tonorezos ES; National Cancer Institute, Bethesda, Maryland, USA.; Weill Cornell Medicine, New York, New York, USA.; Widemann BC; National Cancer Institute, Bethesda, Maryland, USA.; Gibbons HA; National Cancer Institute, Bethesda, Maryland, USA.; Holohan MK; National Cancer Institute, Bethesda, Maryland, USA.; Ababiya ZA; National Cancer Institute, Bethesda, Maryland, USA.; Guidry Auvil JM; National Cancer Institute, Bethesda, Maryland, USA.; Lowy DR; National Cancer Institute, Bethesda, Maryland, USA.; Doroshow JH; National Cancer Institute, Bethesda, Maryland, USA.; Lubenow AE; National Cancer Institute, Bethesda, Maryland, USA.; Reaman GH; National Cancer Institute, Bethesda, Maryland, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: In Process; MEDLINE

Davoudi Z; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Dexheimer TS; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Coussens NP; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Silvers T; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Fox RG; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Kemp SB; Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Juneja P; Molecular Characterization and Clinical Assay Development Laboratory, Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Morris J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Hollingshead MG; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Teicher BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Teicher BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, 20892, USA. Beverly.Teicher@nih.gov.; Molecular Pharmacology Branch, National Cancer Institute, RM 4-W602, MSC 9735, 9609 Medical Center Drive, Bethesda, MD, 20892, USA. Beverly.Teicher@nih.gov.; Dexheimer TS; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.; Silvers T; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.; Coussens NP; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.; Jones E; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.; Gore SD; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, 20892, USA.; Kunkel M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, 20892, USA.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, 20892, USA.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Evrard YA; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Alcoser SY; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Mullendore M; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Chen L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.; Lih CJ; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.; Kannan VR; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.; Datta V; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.; Dutko L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.; Jiwani S; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.; Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Zhao Y; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.; Palmisano A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; General Dynamics Information Technology (GDIT), Falls Church, VA, United States.; Kuhlmann L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Simpson M; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Kummar S; Division of Hematology/Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR, United States.; Das B; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.; Karlovich C; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.; Polley E; Department of Public Health Sciences, University of Chicago, Chicago, IL, United States.; Li MC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Hollingshead MG; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Teicher BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, United States of America. Electronic address: Beverly.Teicher@nih.gov.; Dexheimer TS; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States of America.; Chen L; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States of America.; Silvers T; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States of America.; Jones EM; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States of America.; Coussens NP; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States of America.; Eder JP; Yale University School of Medicine, New Haven, CT 06510, United States of America.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, United States of America.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370711 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0945 (Electronic) Linking ISSN: 00144800 NLM ISO Abbreviation: Exp Mol Pathol Subsets: MEDLINE

Funk AL; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute at Frederick, NIH, Frederick, MD 21702, USA.; Katerji M; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute at Frederick, NIH, Frederick, MD 21702, USA.; Afifi M; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892-4255, USA.; Nyswaner K; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute at Frederick, NIH, Frederick, MD 21702, USA.; Woodroofe CC; Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, NIH, Rockville, MD 20850, USA.; Edwards ZC; Cell Division Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK.; Lindberg E; Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, NIH, Rockville, MD 20850, USA.; Bergman KL; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute at Frederick, NIH, Frederick, MD 21702, USA.; Gough NR; BioSerendipity, LLC, Elkridge, MD 21075, USA.; Rubin MR; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute at Frederick, NIH, Frederick, MD 21702, USA.; Karpińska K; Laboratory of Molecular OncoSignalling, IMol Polish Academy of Sciences, Warsaw, Poland.; Trotter EW; Cell Division Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK.; Dash S; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute at Frederick, NIH, Frederick, MD 21702, USA.; Ries AL; Laboratory Animal Sciences Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; James A; Laboratory Animal Sciences Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Robinson CM; Laboratory Animal Sciences Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Difilippantonio S; Laboratory Animal Sciences Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Karim BO; Molecular Histopathology Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Chang TC; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Chen L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Xu X; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Rockville, MD 20850, USA.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Rockville, MD 20850, USA.; Ahel I; Sir William Dunn School of Pathology, Oxford OX1 3RE, UK.; Marusiak AA; Laboratory of Molecular OncoSignalling, IMol Polish Academy of Sciences, Warsaw, Poland.; Swenson RE; Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, NIH, Rockville, MD 20850, USA.; Cappell SD; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892-4255, USA.; Brognard J; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute at Frederick, NIH, Frederick, MD 21702, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101465400 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1937-9145 (Electronic) Linking ISSN: 19450877 NLM ISO Abbreviation: Sci Signal Subsets: MEDLINE

Negi V; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Bertoli R; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Tuckey O; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Zhu YJ; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Walker RL; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Difilippantonio MJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Meltzer PS; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Aplan PD; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD.

Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Krushkal J; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA.; Zhao Y; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA.; Roney K; Department of Biostatistics and Bioinformatics, George Washington University, Washington, DC, USA.; Zhu W; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Brooks A; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Wilsker D; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Parchment RE; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA.; Doroshow JH; Division of Cancer Treatment and Diagnosis and Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101265293 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2308 (Electronic) Linking ISSN: 15592294 NLM ISO Abbreviation: Epigenetics Subsets: MEDLINE

Yeung CCS; Molecular Oncology Laboratory, Translational Science and Transplantation Division, Fred Hutchinson Cancer Center, Seattle, Washington. Electronic address: cyeung@fredhutch.org.; Narava SK; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Chang TC; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Saeed M; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Aicher L; Molecular Oncology Laboratory, Translational Science and Transplantation Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Beppu LW; Molecular Oncology Laboratory, Translational Science and Transplantation Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Majano MS; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Taylor EM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Camalier CE; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Sandhuria P; Molecular Oncology Laboratory, Translational Science and Transplantation Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Sala-Torra O; Molecular Oncology Laboratory, Translational Science and Transplantation Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Li J; National Cancer Institute, Bethesda, Maryland.; Yee LM; National Cancer Institute, Bethesda, Maryland.; McShane LM; National Cancer Institute, Bethesda, Maryland.; Karlovich C; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Little RF; National Cancer Institute, Bethesda, Maryland.; Harris L; National Cancer Institute, Bethesda, Maryland.; Doroshow JH; National Cancer Institute, Bethesda, Maryland.; Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Radich JP; Molecular Oncology Laboratory, Translational Science and Transplantation Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Jiwani S; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.

Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE

Sorg BS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Byun JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Westbrook VA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Herrick WG; Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.; Tran HL; Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.; Tomaino FR; Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.; Beall B; Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.; Govindharajulu J; Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.; Esposito D; Protein Expression Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.; Kuhlmann L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, 20892, USA.; Parchment RE; Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, 20892, USA.; Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA.; Srivastava AK; Clinical Pharmacodynamics Biomarker Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA. Srivastavaa4@nih.gov.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Morgan, RJ; Doroshow, JH; Leong, L; Schriber, J; Shibata, S; Forman, S; Hamasaki, V; Margolin, K; Somlo, G; Alvarnas, J; McNamara, M; Longmate, J; Raschko, J; Chow, W; Vasilev, S; McGonigle, K; Yen, Y

Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 28(9):859-863

O'Sullivan Coyne G; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Do KT; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA.; Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Piha-Paul S; The University of Texas MD Anderson Cancer Center, Houston, TX.; Rubinstein L; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Kinders R; Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.; Parchment RE; Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.; Wilsker D; Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.; Ferry-Galow K; Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.; Miller B; Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.; Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Juwara L; Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research, Frederick, MD.; Ong MJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Bruns A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Hogu M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Naqash AR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Mittra A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Voth AR; Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Shin SJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; O'Sullivan Coyne G; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Miller SB; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Johnson BC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Anderson L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Rubinstein L; Biometric Research Program, National Cancer Institute, Bethesda, Maryland.; Miller B; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Wilsker DF; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Ferry-Galow KV; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Piekarz R; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Zlott J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Hogu M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Juwara L; Clinical Monitoring Research Program, Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Krushkal J; Biometric Research Program, National Cancer Institute, Bethesda, Maryland.; Konaté M; Biometric Research Program, National Cancer Institute, Bethesda, Maryland.; Palmisano A; Biometric Research Program, National Cancer Institute, Bethesda, Maryland.; Zhao Y; Biometric Research Program, National Cancer Institute, Bethesda, Maryland.; Collins J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Parchment RE; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE